CHRS Interest Expense

Coherus Oncology Inc · Interest Expense

CHRS logo

CHRS Interest Expense

Latest reported$9.08M
CHRS TTM Interest Expense ($5.29M → $9.08M)
High-resolution chart · PNG

CHRS interest expense history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Coherus Oncology Inc Interest Expense — Trailing twelve months (TTM) (USD)
Period endingInterest Expense (USD)
9,083,000
9,037,000
9,001,000
12,098,000
15,135,000
18,192,000
27,158,000
32,431,000
37,337,000
41,946,000
40,542,000
39,308,000
36,580,000
33,217,000
32,474,000
28,882,000
27,113,000
26,280,000
22,959,000
22,837,000
22,722,000
22,383,000
21,166,000
19,978,000
18,791,000
17,816,000
17,601,000
15,552,000
13,508,000
11,492,000
9,684,000
9,650,000
9,617,000
9,584,000
9,552,000
9,521,000
9,549,000
9,519,000
7,980,000
5,611,000
3,224,000
870,000
33,000
33,000
1,000
1,159,000
3,900,000
7,201,000
9,192,000
8,034,000
5,293,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.